AstraZeneca wins US FDA approval for Tezspire in chronic rhinosinusitis with nasal polyps

Faron Pharmaceuticals reports stronger bexmarilimab data at ESMO 2025

CStone announces Phase I CS2009 data at ESMO 2025

AstraZeneca's Saphnelo recommended by CHMP for the treatment of systemic lupus erythematosus in Europe

Ascletis completes enrolment in Phase IIa US study of ASC30 for obesity

CARsgen presents satri-cel preliminary results for adjuvant therapy of pancreatic cancer at ESMO Congress 2025

Antengene reveals ATG-022 clinical data at ESMO 2025

Sichuan Kelun-Biotech presents positive Phase 3 trial results for sac-TMT

SOPHiA DDM Digital Twins launched to simulate patient outcomes and support oncology decisions

Samsung to invest USD110m in GRAIL and commercialise cancer detection test Galleri in Asia

Jacobio Pharma partners with Oceanpine Capital to focus on core oncology pipeline

Viatris acquires Aculys Pharma including certain development and commercialisation rights

Akeso's HARMONi-6 ivonescimab Phase III study accepted by The Lancet and selected for ESMO 2025 presentation

MedAcuity and Haply Robotics Form Strategic Alliance to Advance High-Precision Haptics in Medical and Robotic Systems

AstraZeneca expands Texas facility with USD445m investment to boost Lokelma production